Antipyretic Analgesics Industry Research Report 2023

Antipyretic Analgesics Industry Research Report 2023


Antipyretic Analgesics (algesics) are drugs that can make the body temperature of a febrile patient return to normal, but have no effect on normal body temperature. These drugs also have moderate analgesic effects, but not as strong as morphine and its synthetic substitutes. Commonly used antipyretic and analgesic drugs can be divided into salicylic acid, aniline and pyrazolone according to their chemical structure. Among them, except aniline drugs have anti-rheumatic effect, but also can treat rheumatism and rheumatoid arthritis.

Highlights

The global Antipyretic Analgesics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
From the perspective of product market application, adult antipyretic and analgesic drugs occupy the vast majority of product market application.
Antipyretic analgesic of the world's main producers have Mallinckrodt Pharmaceuticals, IOL, ruan pharmaceutical, Novacyl, basf, bbca pharmaceutical, hubei hundred Cohen di pharmaceutical co., LTD., xinhua pharmaceutical, Granules India Limited, changshu port of China, hebei JiHeng, zhejiang kangle pharmaceutical company, the professional medical technology co., LTD. Hebei province and hunan zhongnan pharmaceutical co., LTD., etc., together with the market share of around 60%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antipyretic Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antipyretic Analgesics.
The Antipyretic Analgesics market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Antipyretic Analgesics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antipyretic Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights


In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Mallinckrodt Pharmaceuticals
IOL
Anqiu Lu'an Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
Hebei Jingye Medical Technology
MSPF

Product Type Insights

Global markets are presented by Antipyretic Analgesics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Antipyretic Analgesics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Antipyretic Analgesics segment by Type

Paracetamol
Aspirin
Ibuprofen
Naproxen
Diclofenac
Oxaprozin
Dexibuprofen
Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Antipyretic Analgesics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Antipyretic Analgesics market.
Antipyretic Analgesics segment by Application

Adults
Children

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Antipyretic Analgesics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antipyretic Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Antipyretic Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Antipyretic Analgesics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antipyretic Analgesics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antipyretic Analgesics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antipyretic Analgesics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antipyretic Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Frequently Asked Questions

Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Antipyretic Analgesics Market Size (2018-2029) & (US$ Million)
2.2.2 Global Antipyretic Analgesics Sales (2018-2029)
2.2.3 Global Antipyretic Analgesics Market Average Price (2018-2029)
2.3 Antipyretic Analgesics by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Paracetamol
1.2.3 Aspirin
1.2.4 Ibuprofen
1.2.5 Naproxen
1.2.6 Diclofenac
1.2.7 Oxaprozin
1.2.8 Dexibuprofen
1.2.9 Others
2.4 Antipyretic Analgesics by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Adults
2.4.3 Children
3 Market Competitive Landscape by Manufacturers
3.1 Global Antipyretic Analgesics Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Antipyretic Analgesics Sales (MT) of Manufacturers (2018-2023)
3.3 Global Antipyretic Analgesics Revenue of Manufacturers (2018-2023)
3.4 Global Antipyretic Analgesics Average Price by Manufacturers (2018-2023)
3.5 Global Antipyretic Analgesics Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Antipyretic Analgesics, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Antipyretic Analgesics, Product Type & Application
3.8 Global Manufacturers of Antipyretic Analgesics, Date of Enter into This Industry
3.9 Global Antipyretic Analgesics Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Mallinckrodt Pharmaceuticals
4.1.1 Mallinckrodt Pharmaceuticals Company Information
4.1.2 Mallinckrodt Pharmaceuticals Business Overview
4.1.3 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
4.1.5 Mallinckrodt Pharmaceuticals Recent Developments
4.2 IOL
4.2.1 IOL Company Information
4.2.2 IOL Business Overview
4.2.3 IOL Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.2.4 IOL Antipyretic Analgesics Product Portfolio
4.2.5 IOL Recent Developments
4.3 Anqiu Lu'an Pharmaceutical
4.3.1 Anqiu Lu'an Pharmaceutical Company Information
4.3.2 Anqiu Lu'an Pharmaceutical Business Overview
4.3.3 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
4.3.5 Anqiu Lu'an Pharmaceutical Recent Developments
4.4 Novacyl
4.4.1 Novacyl Company Information
4.4.2 Novacyl Business Overview
4.4.3 Novacyl Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Novacyl Antipyretic Analgesics Product Portfolio
4.4.5 Novacyl Recent Developments
4.5 BASF
4.5.1 BASF Company Information
4.5.2 BASF Business Overview
4.5.3 BASF Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BASF Antipyretic Analgesics Product Portfolio
6.5.5 BASF Recent Developments
4.6 Anhui BBCA Pharmaceuticals
4.6.1 Anhui BBCA Pharmaceuticals Company Information
4.6.2 Anhui BBCA Pharmaceuticals Business Overview
4.6.3 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
4.6.5 Anhui BBCA Pharmaceuticals Recent Developments
4.7 Hubei Biocause
4.7.1 Hubei Biocause Company Information
4.7.2 Hubei Biocause Business Overview
4.7.3 Hubei Biocause Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Hubei Biocause Antipyretic Analgesics Product Portfolio
4.7.5 Hubei Biocause Recent Developments
6.8 Xinhua Pharm
4.8.1 Xinhua Pharm Company Information
4.8.2 Xinhua Pharm Business Overview
4.8.3 Xinhua Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Xinhua Pharm Antipyretic Analgesics Product Portfolio
4.8.5 Xinhua Pharm Recent Developments
4.9 Granules India Limited
4.9.1 Granules India Limited Company Information
4.9.2 Granules India Limited Business Overview
4.9.3 Granules India Limited Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Granules India Limited Antipyretic Analgesics Product Portfolio
4.9.5 Granules India Limited Recent Developments
4.10 Huagang Pharm
4.10.1 Huagang Pharm Company Information
4.10.2 Huagang Pharm Business Overview
4.10.3 Huagang Pharm Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Huagang Pharm Antipyretic Analgesics Product Portfolio
4.10.5 Huagang Pharm Recent Developments
6.11 Hebei Jiheng Pharmaceutical
6.11.1 Hebei Jiheng Pharmaceutical Company Information
6.11.2 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Business Overview
6.11.3 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
6.11.5 Hebei Jiheng Pharmaceutical Recent Developments
6.12 Zhejiang Kangle Pharmaceutical
6.12.1 Zhejiang Kangle Pharmaceutical Company Information
6.12.2 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Business Overview
6.12.3 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
6.12.5 Zhejiang Kangle Pharmaceutical Recent Developments
6.13 Hebei Jingye Medical Technology
6.13.1 Hebei Jingye Medical Technology Company Information
6.13.2 Hebei Jingye Medical Technology Antipyretic Analgesics Business Overview
6.13.3 Hebei Jingye Medical Technology Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
6.13.5 Hebei Jingye Medical Technology Recent Developments
6.14 MSPF
6.14.1 MSPF Company Information
6.14.2 MSPF Antipyretic Analgesics Business Overview
6.14.3 MSPF Antipyretic Analgesics Sales, Revenue and Gross Margin (2018-2023)
6.14.4 MSPF Antipyretic Analgesics Product Portfolio
6.14.5 MSPF Recent Developments
5 Global Antipyretic Analgesics Market Scenario by Region
5.1 Global Antipyretic Analgesics Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Antipyretic Analgesics Sales by Region: 2018-2029
5.2.1 Global Antipyretic Analgesics Sales by Region: 2018-2023
5.2.2 Global Antipyretic Analgesics Sales by Region: 2024-2029
5.3 Global Antipyretic Analgesics Revenue by Region: 2018-2029
5.3.1 Global Antipyretic Analgesics Revenue by Region: 2018-2023
5.3.2 Global Antipyretic Analgesics Revenue by Region: 2024-2029
5.4 North America Antipyretic Analgesics Market Facts & Figures by Country
5.4.1 North America Antipyretic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Antipyretic Analgesics Sales by Country (2018-2029)
5.4.3 North America Antipyretic Analgesics Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Antipyretic Analgesics Market Facts & Figures by Country
5.5.1 Europe Antipyretic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Antipyretic Analgesics Sales by Country (2018-2029)
5.5.3 Europe Antipyretic Analgesics Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Antipyretic Analgesics Market Facts & Figures by Country
5.6.1 Asia Pacific Antipyretic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Antipyretic Analgesics Sales by Country (2018-2029)
5.6.3 Asia Pacific Antipyretic Analgesics Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Antipyretic Analgesics Market Facts & Figures by Country
5.7.1 Latin America Antipyretic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Antipyretic Analgesics Sales by Country (2018-2029)
5.7.3 Latin America Antipyretic Analgesics Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Antipyretic Analgesics Market Facts & Figures by Country
5.8.1 Middle East and Africa Antipyretic Analgesics Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Antipyretic Analgesics Sales by Country (2018-2029)
5.8.3 Middle East and Africa Antipyretic Analgesics Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Antipyretic Analgesics Sales by Type (2018-2029)
6.1.1 Global Antipyretic Analgesics Sales by Type (2018-2029) & (MT)
6.1.2 Global Antipyretic Analgesics Sales Market Share by Type (2018-2029)
6.2 Global Antipyretic Analgesics Revenue by Type (2018-2029)
6.2.1 Global Antipyretic Analgesics Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Antipyretic Analgesics Revenue Market Share by Type (2018-2029)
6.3 Global Antipyretic Analgesics Price by Type (2018-2029)
7 Segment by Application
7.1 Global Antipyretic Analgesics Sales by Application (2018-2029)
7.1.1 Global Antipyretic Analgesics Sales by Application (2018-2029) & (MT)
7.1.2 Global Antipyretic Analgesics Sales Market Share by Application (2018-2029)
7.2 Global Antipyretic Analgesics Revenue by Application (2018-2029)
6.2.1 Global Antipyretic Analgesics Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Antipyretic Analgesics Revenue Market Share by Application (2018-2029)
7.3 Global Antipyretic Analgesics Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Antipyretic Analgesics Value Chain Analysis
8.1.1 Antipyretic Analgesics Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Antipyretic Analgesics Production Mode & Process
8.2 Antipyretic Analgesics Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Antipyretic Analgesics Distributors
8.2.3 Antipyretic Analgesics Customers
9 Global Antipyretic Analgesics Analyzing Market Dynamics
9.1 Antipyretic Analgesics Industry Trends
9.2 Antipyretic Analgesics Industry Drivers
9.3 Antipyretic Analgesics Industry Opportunities and Challenges
9.4 Antipyretic Analgesics Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Antipyretic Analgesics Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Antipyretic Analgesics Sales (MT) of Manufacturers (2018-2023)
Table 7. Global Antipyretic Analgesics Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Antipyretic Analgesics Revenue of Manufacturers (2018-2023)
Table 9. Global Antipyretic Analgesics Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Antipyretic Analgesics Average Price (USD/Kg) of Manufacturers (2018-2023)
Table 11. Global Antipyretic Analgesics Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Antipyretic Analgesics, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antipyretic Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Mallinckrodt Pharmaceuticals Company Information
Table 17. Mallinckrodt Pharmaceuticals Business Overview
Table 18. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 19. Mallinckrodt Pharmaceuticals Antipyretic Analgesics Product Portfolio
Table 20. Mallinckrodt Pharmaceuticals Recent Developments
Table 21. IOL Company Information
Table 22. IOL Business Overview
Table 23. IOL Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 24. IOL Antipyretic Analgesics Product Portfolio
Table 25. IOL Recent Developments
Table 26. Anqiu Lu'an Pharmaceutical Company Information
Table 27. Anqiu Lu'an Pharmaceutical Business Overview
Table 28. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 29. Anqiu Lu'an Pharmaceutical Antipyretic Analgesics Product Portfolio
Table 30. Anqiu Lu'an Pharmaceutical Recent Developments
Table 31. Novacyl Company Information
Table 32. Novacyl Business Overview
Table 33. Novacyl Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 34. Novacyl Antipyretic Analgesics Product Portfolio
Table 35. Novacyl Recent Developments
Table 36. BASF Company Information
Table 37. BASF Business Overview
Table 38. BASF Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 39. BASF Antipyretic Analgesics Product Portfolio
Table 40. BASF Recent Developments
Table 41. Anhui BBCA Pharmaceuticals Company Information
Table 42. Anhui BBCA Pharmaceuticals Business Overview
Table 43. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 44. Anhui BBCA Pharmaceuticals Antipyretic Analgesics Product Portfolio
Table 45. Anhui BBCA Pharmaceuticals Recent Developments
Table 46. Hubei Biocause Company Information
Table 47. Hubei Biocause Business Overview
Table 48. Hubei Biocause Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 49. Hubei Biocause Antipyretic Analgesics Product Portfolio
Table 50. Hubei Biocause Recent Developments
Table 51. Xinhua Pharm Company Information
Table 52. Xinhua Pharm Business Overview
Table 53. Xinhua Pharm Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 54. Xinhua Pharm Antipyretic Analgesics Product Portfolio
Table 55. Xinhua Pharm Recent Developments
Table 56. Granules India Limited Company Information
Table 57. Granules India Limited Business Overview
Table 58. Granules India Limited Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 59. Granules India Limited Antipyretic Analgesics Product Portfolio
Table 60. Granules India Limited Recent Developments
Table 61. Huagang Pharm Company Information
Table 62. Huagang Pharm Business Overview
Table 63. Huagang Pharm Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 64. Huagang Pharm Antipyretic Analgesics Product Portfolio
Table 65. Huagang Pharm Recent Developments
Table 66. Hebei Jiheng Pharmaceutical Company Information
Table 67. Hebei Jiheng Pharmaceutical Business Overview
Table 68. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 69. Hebei Jiheng Pharmaceutical Antipyretic Analgesics Product Portfolio
Table 70. Hebei Jiheng Pharmaceutical Recent Developments
Table 71. Zhejiang Kangle Pharmaceutical Company Information
Table 72. Zhejiang Kangle Pharmaceutical Business Overview
Table 73. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 74. Zhejiang Kangle Pharmaceutical Antipyretic Analgesics Product Portfolio
Table 75. Zhejiang Kangle Pharmaceutical Recent Developments
Table 76. Hebei Jingye Medical Technology Company Information
Table 77. Hebei Jingye Medical Technology Business Overview
Table 78. Hebei Jingye Medical Technology Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 79. Hebei Jingye Medical Technology Antipyretic Analgesics Product Portfolio
Table 80. Hebei Jingye Medical Technology Recent Developments
Table 81. MSPF Company Information
Table 82. MSPF Business Overview
Table 83. MSPF Antipyretic Analgesics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 84. MSPF Antipyretic Analgesics Product Portfolio
Table 85. MSPF Recent Developments
Table 86. Global Antipyretic Analgesics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 87. Global Antipyretic Analgesics Sales by Region (2018-2023) & (MT)
Table 88. Global Antipyretic Analgesics Sales Market Share by Region (2018-2023)
Table 89. Global Antipyretic Analgesics Sales by Region (2024-2029) & (MT)
Table 90. Global Antipyretic Analgesics Sales Market Share by Region (2024-2029)
Table 91. Global Antipyretic Analgesics Revenue by Region (2018-2023) & (US$ Million)
Table 92. Global Antipyretic Analgesics Revenue Market Share by Region (2018-2023)
Table 93. Global Antipyretic Analgesics Revenue by Region (2024-2029) & (US$ Million)
Table 94. Global Antipyretic Analgesics Revenue Market Share by Region (2024-2029)
Table 95. North America Antipyretic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. North America Antipyretic Analgesics Sales by Country (2018-2023) & (MT)
Table 97. North America Antipyretic Analgesics Sales by Country (2024-2029) & (MT)
Table 98. North America Antipyretic Analgesics Revenue by Country (2018-2023) & (US$ Million)
Table 99. North America Antipyretic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 100. Europe Antipyretic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Europe Antipyretic Analgesics Sales by Country (2018-2023) & (MT)
Table 102. Europe Antipyretic Analgesics Sales by Country (2024-2029) & (MT)
Table 103. Europe Antipyretic Analgesics Revenue by Country (2018-2023) & (US$ Million)
Table 104. Europe Antipyretic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 105. Asia Pacific Antipyretic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Asia Pacific Antipyretic Analgesics Sales by Country (2018-2023) & (MT)
Table 107. Asia Pacific Antipyretic Analgesics Sales by Country (2024-2029) & (MT)
Table 108. Asia Pacific Antipyretic Analgesics Revenue by Country (2018-2023) & (US$ Million)
Table 109. Asia Pacific Antipyretic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 110. Latin America Antipyretic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Latin America Antipyretic Analgesics Sales by Country (2018-2023) & (MT)
Table 112. Latin America Antipyretic Analgesics Sales by Country (2024-2029) & (MT)
Table 113. Latin America Antipyretic Analgesics Revenue by Country (2018-2023) & (US$ Million)
Table 114. Latin America Antipyretic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 115. Middle East and Africa Antipyretic Analgesics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. Middle East and Africa Antipyretic Analgesics Sales by Country (2018-2023) & (MT)
Table 117. Middle East and Africa Antipyretic Analgesics Sales by Country (2024-2029) & (MT)
Table 118. Middle East and Africa Antipyretic Analgesics Revenue by Country (2018-2023) & (US$ Million)
Table 119. Middle East and Africa Antipyretic Analgesics Revenue by Country (2024-2029) & (US$ Million)
Table 120. Global Antipyretic Analgesics Sales by Type (2018-2023) & (MT)
Table 121. Global Antipyretic Analgesics Sales by Type (2024-2029) & (MT)
Table 122. Global Antipyretic Analgesics Sales Market Share by Type (2018-2023)
Table 123. Global Antipyretic Analgesics Sales Market Share by Type (2024-2029)
Table 124. Global Antipyretic Analgesics Revenue by Type (2018-2023) & (US$ Million)
Table 125. Global Antipyretic Analgesics Revenue by Type (2024-2029) & (US$ Million)
Table 126. Global Antipyretic Analgesics Revenue Market Share by Type (2018-2023)
Table 127. Global Antipyretic Analgesics Revenue Market Share by Type (2024-2029)
Table 128. Global Antipyretic Analgesics Price by Type (2018-2023) & (USD/Kg)
Table 129. Global Antipyretic Analgesics Price by Type (2024-2029) & (USD/Kg)
Table 130. Global Antipyretic Analgesics Sales by Application (2018-2023) & (MT)
Table 131. Global Antipyretic Analgesics Sales by Application (2024-2029) & (MT)
Table 132. Global Antipyretic Analgesics Sales Market Share by Application (2018-2023)
Table 133. Global Antipyretic Analgesics Sales Market Share by Application (2024-2029)
Table 134. Global Antipyretic Analgesics Revenue by Application (2018-2023) & (US$ Million)
Table 135. Global Antipyretic Analgesics Revenue by Application (2024-2029) & (US$ Million)
Table 136. Global Antipyretic Analgesics Revenue Market Share by Application (2018-2023)
Table 137. Global Antipyretic Analgesics Revenue Market Share by Application (2024-2029)
Table 138. Global Antipyretic Analgesics Price by Application (2018-2023) & (USD/Kg)
Table 139. Global Antipyretic Analgesics Price by Application (2024-2029) & (USD/Kg)
Table 140. Key Raw Materials
Table 141. Raw Materials Key Suppliers
Table 142. Antipyretic Analgesics Distributors List
Table 143. Antipyretic Analgesics Customers List
Table 144. Antipyretic Analgesics Industry Trends
Table 145. Antipyretic Analgesics Industry Drivers
Table 146. Antipyretic Analgesics Industry Restraints
Table 147. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Antipyretic AnalgesicsProduct Picture
Figure 5. Global Antipyretic Analgesics Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Antipyretic Analgesics Market Size (2018-2029) & (US$ Million)
Figure 7. Global Antipyretic Analgesics Sales (2018-2029) & (MT)
Figure 8. Global Antipyretic Analgesics Average Price (USD/Kg) & (2018-2029)
Figure 9. Paracetamol Product Picture
Figure 10. Aspirin Product Picture
Figure 11. Ibuprofen Product Picture
Figure 12. Naproxen Product Picture
Figure 13. Diclofenac Product Picture
Figure 14. Oxaprozin Product Picture
Figure 15. Dexibuprofen Product Picture
Figure 16. Others Product Picture
Figure 17. Adults Product Picture
Figure 18. Children Product Picture
Figure 19. Global Antipyretic Analgesics Revenue Share by Manufacturers in 2022
Figure 20. Global Manufacturers of Antipyretic Analgesics, Manufacturing Sites & Headquarters
Figure 21. Global Manufacturers of Antipyretic Analgesics, Date of Enter into This Industry
Figure 22. Global Top 5 and 10 Antipyretic Analgesics Players Market Share by Revenue in 2022
Figure 23. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Global Antipyretic Analgesics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. Global Antipyretic Analgesics Sales by Region in 2022
Figure 26. Global Antipyretic Analgesics Revenue by Region in 2022
Figure 27. North America Antipyretic Analgesics Market Size by Country in 2022
Figure 28. North America Antipyretic Analgesics Sales Market Share by Country (2018-2029)
Figure 29. North America Antipyretic Analgesics Revenue Market Share by Country (2018-2029)
Figure 30. United States Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Europe Antipyretic Analgesics Market Size by Country in 2022
Figure 33. Europe Antipyretic Analgesics Sales Market Share by Country (2018-2029)
Figure 34. Europe Antipyretic Analgesics Revenue Market Share by Country (2018-2029)
Figure 35. Germany Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. France Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. U.K. Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Italy Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Russia Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Asia Pacific Antipyretic Analgesics Market Size by Country in 2022
Figure 41. Asia Pacific Antipyretic Analgesics Sales Market Share by Country (2018-2029)
Figure 42. Asia Pacific Antipyretic Analgesics Revenue Market Share by Country (2018-2029)
Figure 43. China Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Japan Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. South Korea Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. India Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Australia Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. China Taiwan Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Indonesia Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Thailand Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Malaysia Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Latin America Antipyretic Analgesics Market Size by Country in 2022
Figure 53. Latin America Antipyretic Analgesics Sales Market Share by Country (2018-2029)
Figure 54. Latin America Antipyretic Analgesics Revenue Market Share by Country (2018-2029)
Figure 55. Mexico Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Brazil Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Argentina Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Middle East and Africa Antipyretic Analgesics Market Size by Country in 2022
Figure 59. Middle East and Africa Antipyretic Analgesics Sales Market Share by Country (2018-2029)
Figure 60. Middle East and Africa Antipyretic Analgesics Revenue Market Share by Country (2018-2029)
Figure 61. Turkey Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 62. Saudi Arabia Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 63. UAE Antipyretic Analgesics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 64. Global Antipyretic Analgesics Sales Market Share by Type (2018-2029)
Figure 65. Global Antipyretic Analgesics Revenue Market Share by Type (2018-2029)
Figure 66. Global Antipyretic Analgesics Price (USD/Kg) by Type (2018-2029)
Figure 67. Global Antipyretic Analgesics Sales Market Share by Application (2018-2029)
Figure 68. Global Antipyretic Analgesics Revenue Market Share by Application (2018-2029)
Figure 69. Global Antipyretic Analgesics Price (USD/Kg) by Application (2018-2029)
Figure 70. Antipyretic Analgesics Value Chain
Figure 71. Antipyretic Analgesics Production Mode & Process
Figure 72. Direct Comparison with Distribution Share
Figure 73. Distributors Profiles
Figure 74. Antipyretic Analgesics Industry Opportunities and Challenges

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings